Details for New Drug Application (NDA): 075845
✉ Email this page to a colleague
The generic ingredient in OXAPROZIN is oxaprozin. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
Summary for 075845
Tradename: | OXAPROZIN |
Applicant: | Abraxeolus |
Ingredient: | oxaprozin |
Patents: | 0 |
Pharmacology for NDA: 075845
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 075845
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OXAPROZIN | oxaprozin | TABLET;ORAL | 075845 | ANDA | Eon Labs, Inc. | 0185-0141 | 0185-0141-01 | 100 TABLET in 1 BOTTLE (0185-0141-01) |
OXAPROZIN | oxaprozin | TABLET;ORAL | 075845 | ANDA | St. Mary's Medical Park Pharmacy | 60760-203 | 60760-203-14 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-203-14) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Jan 31, 2001 | TE: | AB | RLD: | No |
Complete Access Available with Subscription